[e-farmacos] Puesto P.4 vacante en EDM/DAP

[e-farmacos@usa.healthnet.org]

E-farmacos: Puesto P.4 vacante en EDM/DAP
-------------------------------------------------------------------------

[Reproducimos este mensaje aparecido en la lista de discusion "e-drug"
por si es de vuestro interes, AF]

Estimados colegas,

Este mensaje es para informaros del anuncio de una plaza P.4 vacante en
EDM/DAP. El plazo de admision de documentacion se cerrara el 16 de marzo
de 2001. 


Title: Scientist Grade: P.4

Official station (country):  Geneva (Switzerland)

Organizational Location/Unit: 
Health Technology and Pharmaceuticals (HTP)
Essential Drugs and Medicines Policy (EDM)
Drug Action Programme (DAP)

Objectives of the programme:

- To contribute to saving lives and improving health by developing
guidance and by collaborating with countries to provide: (1) equity of
access to essential drugs, (2) rational use of drugs, and (3) drug 
quality, safety and efficacy.

The objective of the Drug Action Programme (DAP) is to optimize WHO's
technical support activities to Member States in the field of essential
drugs;  and to integrate the outcomes from the EDM Quality Assurance and
Safety: Medicines (QSM) and Policy, Access and Rational Use (PAR) teams
with EDM's policy, access and rational use programme development
activities.  DAP also liaises with other UN agencies, bilateral donor 
governments and nongovernmental organizations in order to maximize the
impact of its activities.

The successful candidate will:
- Support Member States in formulating a comprehensive national drug
policy (NDP) document and identify relevant pharmaceutical policies to
address the situation in countries.
- Assist Member States and support the regional offices and countries in
the implementation of activities and strategies for different components
of an NDP that will improve the pharmaceutical situation.
- Develop an indicator-based monitoring system to evaluate the impact of
pharmaceutical programmes and WHO work at country level and to assist
countries in setting up a sustained and relevant monitoring system.
- Represent WHO at international, regional and national meetings related
to EDM activities at country level.

Qualifications Required:
Education and Skills:
Graduate degree in medicine or pharmacy. Post graduate degree in public
health or pharmacology would be an asset. Good knowledge of a
comprehensive pharmaceutical system, setting policies and identifying
and implementing relevant strategies to promote access and rational use
and quality drugs at country level. Good knowledge of evaluation and
assessment of the impact and outcomes of pharmaceutical strategies and
programmes, using indicators to direct strategic policies in
pharmaceuticals that are linked to drug information at 
national, regional and global level. Ability to organize, adapt and
provide training on approaches towards the implementation of
pharmaceutical strategies at regional and country level. Ability to
assess proposals, promote implementation of operational research and
gather evidence based on information from pilot activities at country
level relevant to the implementation of a specific pharmaceutical
strategy. It would also be an asset to have strong analytical skills;
ability to manage and efficiently execute programmes involving
financial and human resources; ability to sustain efficient and pleasant
working relationships with government officials, colleagues and other
partners; sensitivity and ability to work in a multicultural
environment; ability to draft precise and concise reports; ability to
work in a team.

Experience:
At least 8 years experience, in both developing and developed countries,
in situation analysis, formulating and monitoring the impact and outcome
of national drug policies and pharmaceutical strategies. At least five
years experience of direct involvement in implementing developing
country drug programmes (policy, legislation, regulation, supply,
procurement, financing, rational drug use).

Languages:
Excellent working knowledge of English or French with a good working
knowledge of the other. Knowledge of other official WHO languages would
be an asset.

Annual salary (net of tax):
US$ 52 503 at single rate and US$ 56 380 with primary dependants. 
Post Adjustment: 31.1% of the above figures. This percentage is to be
considered as indicative since variations may occur each month either
upwards or downwards due to currency exchange rate fluctuations or 
inflation.

Applications should quote the vacancy notice number and include a
detailed curriculum vitae and photograph.

APPLICATIONS WILL ONLY BE ACCEPTED WHEN ACCOMPANIED BY A COMPLETED
PERSONAL HISTORY FORM. For more information see: How to Apply for a
Vacancy

CLOSING DATE FOR APPLICATION:16 MARCH 2001

This vacancy is open to applicants of EITHER SEX. Applications from
WOMEN are encouraged.

Only candidates under serious consideration will be contacted for
interview and test.
Any appointment/extension of appointment is subject to WHO Staff
Regulations, Staff Rules and Manual

Staff are subject to assignment to any office of the WHO in the world
and mobility is encouraged.

Please send your application by mail to:
HTP/MSU
World Health Organization,
CH-1211 Geneva 27,
Switzerland

By fax to: 41 22 7914889

By Email to: htpvac@who.ch
NB: This Email address should ONLY be used for vacancy applications.  
Due to the large number of messages, any other type of correspondence
may not be answered.

WHO has a smoke free environment.

Please consult this WHO webpage for more information on the job
description and requirements.

http://www.who.int/per/vacancies/phq01_004e.htm

German,

Dr. Germann Velasquez
Coordinator
Drug Action Programme (DAP)
Essential Drugs and Medicines Policy (EDM)
World Health Organization
CH-1211 Geneva 27
Switzerland
WWW: http//www.who.int/medicines
Tel. (+4122) 791 35 09 Direct
      (+4122) 791 27 24 Secretary
:(+4122) 791 41 67
velasquezg@who.ch
-
Envíe el correo para la conferencia de `e-farmacos' a:
e-farmacos@usa.healthnet.org
Envíe las peticiones administrativas a:
majordomo@usa.healthnet.org
Para la ayuda adicional, envíe el correo a:
owner-e-farmacos@usa.healthnet.org